Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients

Naoyuki Miyashita, Hiroto Akaike, Hideto Teranishi, Yasuhiro Kawai, Kazunobu Ouchi, Tadashi Kato, Toshikiyo Hayashi, Niro Okimoto, Naoyuki Miyashita, Hiroto Akaike, Hideto Teranishi, Yasuhiro Kawai, Kazunobu Ouchi, Tadashi Kato, Toshikiyo Hayashi, Niro Okimoto

Abstract

Background: Several symptoms are classically thought to be suggestive of pertussis in children, but the diagnostic value of these symptoms in adolescent and adult patients is unclear. We evaluated the accuracy of the clinical findings for the early presumptive diagnosis of pertussis in adolescent and adult patients. Furthermore, we measured fractional exhaled nitric oxide (FeNO) with regard to whether we could distinguish eosinophilic inflammation of the airway and pertussis. FeNO is not expected to be associated with pertussis.

Methods: We compared 183 cases with laboratory-confirmed pertussis using serology and polymerase chain reaction and 1,132 cases without laboratory-confirmed pertussis.

Results: Among pertussis patients, paroxysmal cough was common with 90% sensitivity, but the specificity was low (25%). Posttussive vomiting and whoop were less common (sensitivity 25% and 19%, respectively), but both showed greater specificity for pertussis (80% and 86%, respectively). Posttussive gagging was observed with intermediate frequency and provided greater specificity (49% and 77%, respectively). Pertussis cases were most frequent between May and August with a peak in June. The mean FeNO value for the pertussis patients was 18.2 ± 9.2 ppb, which was significantly lower than that in asthma patients (56.9 ± 20.3 ppb, p <0.001). The most useful definition was posttussive vomiting and/or gagging, and a plus normal FeNO value, which had a sensitivity of 72% and a specificity of 70%.

Conclusions: Clinical symptoms and laboratory data are of limited value in making the diagnosis of pertussis, and it was clinically difficult to differentiate adolescent and adult patients with or without pertussis. However, pertussis should be considered if patients have posttussive vomiting and/or gagging and a normal FeNO concentration.

Figures

Figure 1
Figure 1
Cases of pertussis in adolescent and adult patients by month between 2005 and 2012.

References

    1. Halperin SA. The control of pertusis-2007 and beyond. N Engl J Med. 2007;356(2):110–113. doi: 10.1056/NEJMp068288.
    1. Hewlett EL, Edwards KM. Pertussis-not just for kids. N Engl J Med. 2005;352(12):1215–1222. doi: 10.1056/NEJMcp041025.
    1. Von Koenig CHW, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002;2(12):744–750. doi: 10.1016/S1473-3099(02)00452-8.
    1. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005;24(5):S44–S47.
    1. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, Burns S, Amundson G, Baughman A, Wattigney W. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J Infect Dis. 2001;183(9):1353–1359. doi: 10.1086/319853.
    1. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. Chlamydia pneumoniae infection in adult patients with persistent cough. J Med Microbiol. 2003;52(3):265–269. doi: 10.1099/jmm.0.04986-0.
    1. Cornia PB, Hersh AL, Lipsky BA, Newman TB, Gonzales R. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010;304(8):890–896. doi: 10.1001/jama.2010.1181.
    1. Fujimura M, Abo M, Ogawa H, Nishi K, Kibe Y, Hirose T, Nakatsumi Y, Iwasa K. Importance of atopic cough, cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan. Respirology. 2005;10(2):201–207. doi: 10.1111/j.1440-1843.2005.00686.x.
    1. Matsumoto H, Niimi A, Takemura M, Ueda T, Yamaguchi M, Matsuoka H, Jinnai M, Chin K, Mishima M. Prevalence and clinical manifestations of gastro-oesophageal reflux-associated chronic cough in the Japanese population. Cough. 2007;3(1):1. doi: 10.1186/1745-9974-3-1.
    1. Yamasaki A, Hanaki K, Tomita K, Watanabe M, Hasagawa Y, Okazaki R, Yamamura M, Fukutani K, Sugimoto Y, Kato K, Kodani M, Ikeda T, Konishi T, Kawasaki Y, Tokuyasu H, Yajima H, Sejima H, Isobe T, Shimizu E. Cough and asthma diagnosis: physicians’ diagnosis and treatment of patients complaining of acute, subacute and chronic cough in rural areas of Japan. Int J Gen Med. 2010;3(4):101–107.
    1. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax. 1993;48(10):1034–1043. doi: 10.1136/thx.48.10.1034.
    1. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respi Crit Care Med. 2001;163(7):1693–1722.
    1. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K. Evaluation of serological tests for diagnosis of Bordetella pertussis infection in adolescents and adults. Respirology. 2011;16(8):1189–1195. doi: 10.1111/j.1440-1843.2011.02024.x.
    1. Chatokin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med. 1999;159(6):1810–1813.
    1. Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, McKay A, Thomson NC. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol. 2004;113(6):1063–1070. doi: 10.1016/j.jaci.2004.03.019.
    1. Kowal K, Bodzenta-Lukaszyk A, Zukowski S. Exhaled nitric oxide in evaluation of young adults with chronic cough. J Asthma. 2009;46(7):692–698. doi: 10.1080/02770900903056187.
    1. National Institute of Health, National Heart, Lung, and Blood Institute. Global Initiative For Asthma. Global Strategy For Asthma Management And Prevention 2012 (update) 2008. pp. 1–128. .
    1. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M. Atypical Pathogen Study Group. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis. 2011;30(3):439–446. doi: 10.1007/s10096-010-1107-8.
    1. Riffelmann M, von Konig CH W, Caro V. Guiso N for the Pertussis PCR Consensus Group. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43(10):4925–4929. doi: 10.1128/JCM.43.10.4925-4929.2005.
    1. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Kurose K, Oka M. Outbreak of pertussis in a university laboratory. Intern Med. 2011;50(8):879–885. doi: 10.2169/internalmedicine.50.4768.
    1. Kuno-Sakai H, Kimura M, Ohta K, Oh Y, Kim R, Kobayashi T, Yamamoto E, Fujita I. A simple and sensitive ELISA of antibodies to pertussis antigens. Vaccine. 1992;10(5):350–352. doi: 10.1016/0264-410X(92)90377-V.
    1. American Thoracic Society Documents. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930.
    1. De Serres G, Shadmani R, Duval B, Boulianne N, Dery P, Fradet MD, Rochette L, Halperin SA. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182(7):174–179.
    1. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, Fahimzad A, Shamshiri A, Kahbazi M, Shiva F. Sensitivity and specificity of World Health Organization pertussis clinical case definition. Int J Infect Dis. 2010;14(12):e1072–e1075. doi: 10.1016/j.ijid.2010.07.005.
    1. Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, Davis JP, Manclark CR. Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health. 1988;78(7):833–836. doi: 10.2105/AJPH.78.7.833.
    1. Stehr K, Cherry JD, Heininger U. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics. 1998;101(1 Pt 1):1–11.
    1. Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis. 2005;24(2):156–158. doi: 10.1007/s10096-005-1277-y.
    1. Cherry JD, Tan T, von Koenig CHW, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. Clinical definitions of pertussis: Summary of a global pertussis initiative roundtable meeting, February 2011. Clin Infect Dis. 2012;54(12):1756–1764. doi: 10.1093/cid/cis302.
    1. Altizer S, Dobson A, Hosseini P, Hudson P, Pascual M, Rohani P. Seasonality and the dynamics of infectious diseases. Ecol Lett. 2006;9(4):467–484. doi: 10.1111/j.1461-0248.2005.00879.x.
    1. De Greeff SC, Dekkers AL, Teunis P, Rahamat-Langendoen JC, Mooi FR, De Melker HE. Seasonal patterns in time series of pertussis. Epidemiol Infect. 2009;137(10):1388–1395. doi: 10.1017/S0950268809002489.
    1. Shah AP, Smolensky MH, Burau KD, Cech IM, Lai D. Seasonality of primary childhood and young adult infectious diseases in the United States. Chromob Int. 2006;23(5):1065–1082. doi: 10.1080/07420520600920718.
    1. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, Champagne S, Patrick DM, Harperin SA. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185(10):1448–1453. doi: 10.1086/340280.
    1. Vickers D, Maina-Jaime RC, Pahwa P. Pertussis in rural populations of Saskatchewan (1995 to 2003) Can J Pub Health. 2006;97(6):459–464.
    1. National Institute of Health. Infectious Disease Surveillance Center. Pertussis. .
    1. National Institute of Health. Infectious Disease Surveillance Center. Pertussis 2005–2007. IASR. 2008;29:65–77. .

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren